Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is trading at $285.65, about ₹27,442 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, up 1.73% today. Indian residents can buy Praxis Precision Medicines from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$279.13
Today's high
$292.18
52 week low
$28.79
52 week high
$392.70
PRAX opened at $287.92, closed previously at $280.78, and has traded between $28.79 and $392.70 over the past 52 weeks.
About
Praxis Precision Medicines, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to creating innovative treatments for central nervous system (CNS) conditions that stem from an imbalance in neuronal activity. The company's primary investigational compounds currently undergoing evaluation include: PRAX-114, an extrasynaptic-preferring positive allosteric modulator of the GABAA receptor, which is currently in Phase IIa clinical trials for addressing both major depressive disorder and perimenopausal depression. Additionally, PRAX-944, a small molecule designed to selectively inhibit T-type calcium channels, is also progressing through Phase IIa clinical trials to manage essential tremor. Beyond these, Praxis is also advancing a pipeline of other promising drug candidates, such as: PRAX-562, a persistent sodium current blocker, undergoing Phase I clinical evaluation for treating severe pediatric epilepsy and adult cephalgia (headaches). PRAX-222, an antisense oligonucleotide (ASO) aimed at individuals suffering from gain-of-function (GOF) SCN2A epilepsy. And a program targeting KCNT1 for the treatment of KCNT1 GOF epilepsy. To further its research and development efforts, Praxis maintains several strategic alliances. These include a cooperation and licensing arrangement with RogCon Inc.; a licensing deal with Purdue Neuroscience Company; a comprehensive research collaboration, option, and license agreement with Ionis Pharmaceuticals, Inc.; and a collaborative project with The Florey Institute focused on the creation of three new antisense oligonucleotides (ASOs). Established in 2015, the company's headquarters are situated in Boston, Massachusetts.
Key statistics
Avg. volume
468.08K
Market cap
$7.96B
P/E Ratio
-22.06
Price-to-sales ratio
0.00
Enterprise value
$7.49B
Free cash flow yield
-3.84%
Debt-to-equity ratio
0.00
Return on equity
-34.15%
ROIC
-28.18%
Beta
2.78
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$0.00
Earnings per share
-$13.48
Free cash flow
-$249.12M
Net profit margin
0.00%
Gross margin
0.00%
EBITDA
-$303.13M
Revenue growth
-100.00%
Similar securities
This is not an investment recommendation
How to buy Praxis Precision Medicines from India
Indian residents can buy Praxis Precision Medicines shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Praxis Precision Medicines and place an order
Find Praxis Precision Medicines by name or by its ticker, PRAX, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Praxis Precision Medicines trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Praxis Precision Medicines position in USD and INR. Praxis Precision Medicines pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Praxis Precision Medicines from India
Trading and taxes when buying Praxis Precision Medicines from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NonePraxis Precision Medicines does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Praxis Precision Medicines stock?
Yes. Praxis Precision Medicines (PRAX) has been listed on NASDAQ since 2020, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Praxis Precision Medicines share cost in rupees?
One Praxis Precision Medicines share is $285.65 — about ₹27,442 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the Praxis Precision Medicines price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Praxis Precision Medicines from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy Praxis Precision Medicines with less than the price of one share?
Yes. A whole Praxis Precision Medicines share is $285.65, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.
How are gains on Praxis Precision Medicines shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Praxis Precision Medicines price. Paasa issues a capital-gains statement for your return.
Does Praxis Precision Medicines pay a dividend?
No. Praxis Precision Medicines does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Praxis Precision Medicines from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Praxis Precision Medicines shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Praxis Precision Medicines shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Praxis Precision Medicines holding, its cost and its closing value.
How do I sell Praxis Precision Medicines and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.